Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 250

1.

South African Hypertension Society commentary on the American College of Cardiology/American Heart Association hypertension guidelines.

Rayner B, Jones E, Veriava Y, Seedat YK.

Cardiovasc J Afr. 2019 May/Jun 23;30(3):184-187. doi: 10.5830/CVJA-2019-025. Epub 2019 May 24.

2.

The evidence on the 2018 ESC/ESH Guidelines for the management of arterial hypertension in African ancestry patients.

Brewster LM, van Montfrans GA, Seedat YK.

J Hypertens. 2019 Mar;37(3):650-651. doi: 10.1097/HJH.0000000000002024. No abstract available.

PMID:
30702496
3.

Hypertension and cardiovascular disease in the sub-Saharan African context.

Seedat Y, Ali A, Ferdinand KC.

Ann Transl Med. 2018 Aug;6(15):297. doi: 10.21037/atm.2018.06.45. No abstract available.

4.

Chronic depression symptoms desensitize renin activity to protect against volume-loading hypertension in Blacks: The SABPA study.

De Vos AC, Malan L, Seedat YK, Cockeran M, Malan NT.

Physiol Behav. 2018 Oct 1;194:474-480. doi: 10.1016/j.physbeh.2018.06.038. Epub 2018 Jun 28.

PMID:
29960014
5.

Report of the International Society of Hypertension Teaching Seminar organized by the International Society of Hypertension Africa Regional Advisory Group: Maputo, Mozambique, 2016.

Onwubere B, Coca A, Damasceno A, Kadiri S, Kruger R, Lemogoum D, M'Buyamba-Kabangu JR, Okpechi I, Poulter N, Rayner B, Seedat YK, Schutte AE, Touyz RM.

J Hypertens. 2016 Oct;34(10):2105-7. doi: 10.1097/HJH.0000000000001062.

6.

Systematic review: antihypertensive drug therapy in patients of African and South Asian ethnicity.

Brewster LM, van Montfrans GA, Oehlers GP, Seedat YK.

Intern Emerg Med. 2016 Apr;11(3):355-74. doi: 10.1007/s11739-016-1422-x. Epub 2016 Mar 30. Review.

7.

Why is control of hypertension in sub-Saharan Africa poor?

Seedat YK.

Cardiovasc J Afr. 2015 Jul-Aug;26(4):193-5. doi: 10.5830/CVJA-2015-065. Review.

8.

South African hypertension practice guideline 2014.

Hypertension guideline working group, Seedat YK, Rayner BL, Veriava Y.

Cardiovasc J Afr. 2014 Nov-Dec;25(6):288-94. doi: 10.5830/CVJA-2014-062. Review. Erratum in: Cardiovasc J Afr. 2015 Mar-Apr;26(2):90.

9.

What role does African ancestry play in how hypertensive patients respond to certain antihypertensive drug therapy?

Seedat YK, Brewster LM.

Expert Opin Pharmacother. 2014 Feb;15(2):159-61. doi: 10.1517/14656566.2014.857403. Epub 2013 Nov 12.

PMID:
24215578
11.

Hypertension and diabetes: entry points for prevention and control of the global cardiovascular epidemic.

Mendis S, O'Brien E, Seedat YK, Yusuf S.

Int J Hypertens. 2013;2013:878460. doi: 10.1155/2013/878460. Epub 2013 Apr 7. No abstract available.

12.
13.

Defensive coping, urbanization, and neuroendocrine function in Black Africans: the THUSA study.

Malan L, Hamer M, Reimann M, Huisman H, Van Rooyen J, Schutte A, Schutte R, Potgieter J, Wissing M, Steyn F, Seedat Y, Malan N.

Psychophysiology. 2012 Jun;49(6):807-14. doi: 10.1111/j.1469-8986.2012.01362.x. Epub 2012 Mar 14.

PMID:
22416967
14.

South African hypertension guideline 2011.

Seedat YK, Rayner BL; Southern African Hypertension Society.

S Afr Med J. 2011 Dec 14;102(1 Pt 2):57-83. Erratum in: S Afr Med J. 2012 Feb;102(2):94.

PMID:
22273141
15.

Control of hypertension in South Africa: time for action.

Seedat YK.

S Afr Med J. 2011 Dec 14;102(1):25-6. No abstract available.

PMID:
22273131
16.

Facilitated defensive coping, silent ischaemia and ECG left-ventricular hypertrophy: the SABPA study.

Malan L, Hamer M, Schlaich MP, Lambert GW, Harvey BH, Reimann M, Ziemssen T, de Geus EJ, Huisman HW, van Rooyen JM, Schutte R, Schutte AE, Fourie CM, Seedat YK, Malan NT.

J Hypertens. 2012 Mar;30(3):543-50. doi: 10.1097/HJH.0b013e32834fcf82.

PMID:
22245987
17.

Vascular cause for stridor in infants.

Seedat Y, Andronikou S, Modi M, Lorgat M.

S Afr Med J. 2011 Feb;101(2):102. No abstract available. Erratum in: S Afr Med J. 2011 Aug;101(8):494.

PMID:
21678731
18.

Conventional and behavioral risk factors explain differences in sub-clinical vascular disease between black and Caucasian South Africans: the SABPA study.

Hamer M, Malan L, Schutte AE, Huisman HW, van Rooyen JM, Schutte R, Fourie CM, Malan NT, Seedat YK.

Atherosclerosis. 2011 Mar;215(1):237-42. doi: 10.1016/j.atherosclerosis.2010.12.015. Epub 2010 Dec 21.

PMID:
21208616
19.

Poverty and its impact on diseases in sub-Saharan Africa.

Seedat YK.

Ethn Health. 2010 Aug;15(4):321-3. No abstract available.

PMID:
21171196
20.

The cost of coping: a cardio-neuro-metabolic risk for black South Africans?

Malan L, Malan NT, Du Plessis A, Wissing MP, Potgieter JC, Seedat YK.

Cardiovasc J Afr. 2010 Jul-Aug;21(4):183-5. No abstract available.

Supplemental Content

Loading ...
Support Center